Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematologic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06150469
What this trial is testing

Efficacy of Inhaled Aromatherapy on Nausea and Vomiting in Hematological Malignancies

Who this might be right for
Hematological Malignancies
University Hospital, Limoges 286
Testing effectiveness (Phase 2)Study completedNCT01056523
What this trial is testing

Use of Ribavirin and Low Dose Ara-C to Treat Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Jewish General Hospital 29
Not applicableLooking for participantsNCT04157179
What this trial is testing

Cerebral Oxygen Metabolism in Children

Who this might be right for
Sickle Cell DiseaseCerebral Stroke
Washington University School of Medicine 350
Not applicableStudy completedNCT00230659
What this trial is testing

Investigation of Coagulation Parameters in Hereditary Haemorrhagic Telangiectasia

Who this might be right for
Telangiectasia, Hereditary Hemorrhagic
Imperial College London 100
Not applicableStudy completedNCT04436380
What this trial is testing

Retrospective Study of Patients With Severe Aplastic Anemia Who Relapsed After Immunosuppressive Therapy

Who this might be right for
Severe Aplastic Anemia
National Heart, Lung, and Blood Institute (NHLBI) 173
Not applicableStudy completedNCT04721262
What this trial is testing

Ferumoxytol Enhanced Hyperfine Low Field Strength MRI

Who this might be right for
Anemia, Hemolytic
University of Pennsylvania 2
Not applicableNot Yet RecruitingNCT07751588
What this trial is testing

Plasma ctDNA Monitoring in Pediatric Acute Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic Leukemia
Institute of Hematology & Blood Diseases Hospital, China 25
Testing effectiveness (Phase 2)Study completedNCT00776503
What this trial is testing

Vorinostat and Low Dose Cytarabine for High Risk Myelodysplasia

Who this might be right for
Myelodysplastic Syndromes
Groupe Francophone des Myelodysplasies 52
Large-scale testing (Phase 3)Study completedNCT00574873
What this trial is testing

Compare Bosutinib To Imatinib In Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CML

Who this might be right for
Chronic Myeloid Leukemia
Pfizer 502
Not applicableStudy completedNCT01422824
What this trial is testing

An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) as Maintenance Treatment in Patients With Chronic Renal Anemia on Haemodialysis

Who this might be right for
Anemia, Kidney Disease, Chronic
Hoffmann-La Roche 185
Testing effectiveness (Phase 2)Study completedNCT01389024
What this trial is testing

Hydroxyurea to Prevent Brain Injury in Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseStroke
Johns Hopkins University 28
Testing effectiveness (Phase 2)UnknownNCT03823079
What this trial is testing

Comparison of Interleukin-11 and rhTPO for Recurrent Colorectal Cancer Patients With Thrombocytopenia

Who this might be right for
Recurrent Colorectal CarcinomaThrombopenia
Fudan University 50
Testing effectiveness (Phase 2)Study completedNCT00037596
What this trial is testing

Study Evaluating Gemtuzumab Ozogamicin in Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Wyeth is now a wholly owned subsidiary of Pfizer
Testing effectiveness (Phase 2)Study completedNCT02441686
What this trial is testing

Phase II Study of Efficacy and Safety of Lenalidomide, Subcutaneous Bortezomib and Dexamethasone Therapy for Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Dana-Farber Cancer Institute 46
Testing effectiveness (Phase 2)UnknownNCT02834286
What this trial is testing

Rituximab, Eltrombopag and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Hospital Universitario Dr. Jose E. Gonzalez 15
Not applicableStudy completedNCT01544686
What this trial is testing

Antimicrobial Catheter Securement Dressings for the Prevention of Cvc-related Bloodstream Infections in Cancer Patients

Who this might be right for
Bloodstream Infection
University of Cologne 630
Testing effectiveness (Phase 2)Study completedNCT00098670
What this trial is testing

Fludarabine, Rituximab, and Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia

Who this might be right for
B-cell Chronic Lymphocytic LeukemiaStage I Chronic Lymphocytic LeukemiaStage II Chronic Lymphocytic Leukemia+2 more
National Cancer Institute (NCI) 102
Early research (Phase 1)Active Not RecruitingNCT05362773
What this trial is testing

MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies

Who this might be right for
Leukemia, Acute MyeloidMyelodysplastic SyndromesClassical Hodgkin Lymphoma+5 more
MacroGenics 130
Testing effectiveness (Phase 2)Study completedNCT00315705
What this trial is testing

Clofarabine in Combination With Etoposide and Cyclophosphamide in Children With Acute Leukemias.

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaRelapsed Leukemia
Genzyme, a Sanofi Company 50
Not applicableLooking for participantsNCT07579065
What this trial is testing

HematoCare: Feasibility of a Survivorship Care Plan for Hematologic Cancer Patients Undergoing HSCT

Who this might be right for
Hematologic NeoplasmHematopoietic Stem Cell TransplantationSurvivorship+1 more
Azienda USL Reggio Emilia - IRCCS 40
Next Page